Integrated Fluid Control Systems for Enhanced Bodily Fluid Procurement

The inventive concept integrates fluid control devices with distinct technologies such as AI, IoT, blockchain, and nanomaterials to create a more powerful system for procuring bodily fluid samples with reduced contaminants.

The original patent addressed the problem of contaminants in bodily fluid samples, but it had limitations in terms of predicting and adjusting for contaminants, securely storing and tracking samples, and minimizing microbial adhesion and biofilm formation. The new inventive concept solves these problems by integrating the fluid control device with AI, IoT, blockchain, and nanomaterials.

The integrated system consists of a fluid control device, an artificial intelligence module, an IoT-based sensor network, a blockchain-based data storage system, and a nanomaterial-based coating. The AI module predicts and adjusts for contaminants in the bodily fluid flow, while the IoT-based sensor network monitors and controls bodily fluid procurement. The blockchain-based data storage system securely stores and tracks the procured bodily fluid samples, and the nanomaterial-based coating reduces microbial adhesion and biofilm formation. The system optimizes fluid flow and minimizes contamination, ensuring the integrity and authenticity of procured bodily fluid samples.

The new claims introduce the integration of distinct technologies with the fluid control device, which is new and non-obvious compared to the original patent. The use of AI, IoT, blockchain, and nanomaterials provides a synergistic combination that enhances the functionality and effectiveness of the fluid control device.

Alternative embodiments may include integrating the fluid control device with other technologies such as machine learning algorithms, cloud-based data analytics, or advanced materials. Variations may include adapting the system for different types of bodily fluid samples or for use in various medical settings.

The integrated fluid control system has significant commercial potential in the healthcare industry, particularly in the areas of diagnostic testing, medical research, and patient care. The system's ability to provide accurate and reliable bodily fluid samples with reduced contaminants can improve healthcare outcomes and reduce costs.